GENinCode (LON:GENI) Announces Earnings Results

GENinCode (LON:GENI) announced its quarterly earnings results on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative net margin of 185.47% and a negative return on equity of 409.40%.

GENinCode Price Performance

GENI opened at GBX 0.70 on Wednesday. The company has a current ratio of 0.93, a quick ratio of 15.88 and a debt-to-equity ratio of 117.74. The company has a fifty day simple moving average of GBX 0.88 and a 200 day simple moving average of GBX 0.99. The firm has a market cap of £5.27 million, a price-to-earnings ratio of -0.34 and a beta of 0.59. GENinCode has a twelve month low of GBX 0.64 and a twelve month high of GBX 4.90.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.